Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. This is a clinical trial investigating the effectiveness of
using Biphasic Insulin Aspart 70/30 in two different treatment regiments for 6 months in
subjects with type 2 diabetes, not well controlled on their current oral anti-diabetic drug
therapy.